Structure/function relationships underlying regulation of FOXO transcription factors

Oncogene

Volumn 27, Issue 16, 2008, Pages 2263-2275

  Obsil, T ^a,b   Obsilova, V ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

14 3 3 protein; Acetylation; Forkhead transcription factors; FOXO; Phosphorylation; Ubiquitination

Indexed keywords

TRANSCRIPTION FACTOR FOXO;

ACETYLATION; CARBOXY TERMINAL SEQUENCE; DNA BINDING; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

ACETYLATION; ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; STRUCTURE-ACTIVITY RELATIONSHIP; UBIQUITIN;

EID: 41849104205     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.20     Document Type: Review

References (109)

1. Aitken A. (2006). 14-3-3 proteins: a historic overview. Semin Cancer Biol 16: 162-172.
2. Aitken A, Howell S, Jones D, Madrazo J, Patel Y. (1995). 14-3-3 alpha and delta are the phosphorylated forms of raf-activating 14-3-3 beta and zeta. In vivo stoichiometric phosphorylation in brain at a Ser-Pro-Glu-Lys MOTIF. J Biol Chem 270: 5706-5709.
3. Alessi DR, Caudwell FB, Andjelkovic M, Hemmings BA, Cohen P. (1996). Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett 399: 333-338.
4. Anderson MJ, Viars CS, Czekay S, Cavenee WK, Arden KC. (1998). Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 47: 187-199.
5. Asada S, Daitoku H, Matsuzaki H, Saito T, Sudo T, Mukai H et al. (2007). Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. Cell Signal 19: 519-527.
6. Berdichevsky A, Viswanathan M, Horvitz HR, Guarente L. (2006). C.elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span. Cell 125: 1165-1177.
7. Biggs 3rd WH, Cavenee WK, Arden KC. (2001). Identification and characterization of members of the FKHR (FOX O) subclass of winged-helix transcription factors in the mouse. Mamm Genome 12: 416-425.
8. Biggs 3rd WH, Meisenhelder J, Hunter T, Cavenee WK, Arden KC. (1999). Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA 96: 7421-7426.
9. Bois PR, Brochard VF, Salin-Cantegrel AV, Cleveland JL, Grosveld GC. (2005). FoxO1a-cyclic GMP-dependent kinase I interactions orchestrate myoblast fusion. Mol Cell Biol 25: 7645-7656.
10. Borkhardt A, Repp R, Haas OA, Leis T, Harbott J, Kreuder J et al. (1997). Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23). Oncogene 14: 195-202.
11. Boura E, Silhan J, Herman P, Vecer J, Sulc M, Teisinger J et al. (2007). Both the N-terminal loop and wing W2 of the forkhead domain of transcription factor Foxo4 are important for DNA binding. J Biol Chem 282: 8265-8275.
12. Braselmann S, McCormick F. (1995). Bcr and Raf form a complex in vivo via 14-3-3 proteins. EMBO J 14: 4839-4848.
13. Brownawell AM, Kops GJ, Macara IG, Burgering BM. (2001). Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol Cell Biol 21: 3534-3546.
14. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
15. Brunet A, Kanai F, Stehn J, Xu J, Sarbassova D, Frangioni JV et al. (2002). 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J Cell Biol 156: 817-828.
16. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y et al. (2004). Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015.
17. Cahill CM, Tzivion G, Nasrin N, Ogg S, Dore J, Ruvkun G et al. (2001). Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways. J Biol Chem 276: 13402-13410.
18. Carlsson P, Mahlapuu M. (2002). Forkhead transcription factors: key players in development and metabolism. Dev Biol 250: 1-23.
19. Clark KL, Halay ED, Lai E, Burley SK. (1993). Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364: 412-420.
20. Daitoku H, Hatta M, Matsuzaki H, Aratani S, Ohshima T, Miyagishi M et al. (2004). Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci USA 101: 10042-10047.
21. Dalal SN, Schweitzer CM, Gan J, DeCaprio JA. (1999). Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site. Mol Cell Biol 19: 4465-4479.
22. Davis RJ, D'Cruz CM, Lovell MA, Biegel JA, Barr FG. (1994). Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 54: 2869-2872.
23. Dingwall C, Laskey RA. (1991). Nuclear targeting sequences - a consensus? Trends Biochem Sci 16: 478-481.
24. Essers MA, Weijzen S, de Vries-Smits AM, Saarloos I, de Ruiter ND, Bos JL et al. (2004). FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J 23: 4802-4812.
25. Frescas D, Valenti L, Accili D. (2005). Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J Biol Chem 280: 20589-20595.
26. Fu H, Subramanian RR, Masters SC. (2000). 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40: 617-647.
27. Fukuoka M, Daitoku H, Hatta M, Matsuzaki H, Umemura S, Fukamizu A. (2003). Negative regulation of forkhead transcription factor AFX (Foxo4) by CBP-induced acetylation. Int J Mol Med 12: 503-508.
28. Furuyama T, Nakazawa T, Nakano I, Mori N. (2000). Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J 349: 629-634.
29. Gajiwala KS, Burley SK. (2000). Winged helix proteins. Curr Opin Struct Biol 10: 110-116.
30. Galili N, Davis RJ, Fredericks WJ, Mukhopadhyay S, Rauscher 3rd FJ, Emanuel BS et al. (1993). Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet 5: 230-235.
31. Greer EL, Brunet A. (2005). FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24: 7410-7425.
32. Grozinger CM, Schreiber SL. (2000). Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc Natl Acad Sci USA 97: 7835-7840.
33. Guo S, Rena G, Cichy S, He X, Cohen P, Unterman T. (1999). Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J Biol Chem 274: 17184-17192.
34. Hillion J, Le Coniat M, Jonveaux P, Berger R, Bernard OA. (1997). AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily. Blood 90: 3714-3719.
35. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY et al. (2004). IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117: 225-237.
36. Huang H, Regan KM, Wang F, Wang D, Smith DI, van Deursen JM et al. (2005). Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci USA 102: 1649-1654.
37. Huang HJ, Regan KM, Lou ZK, Chen JJ, Tindall DJ. (2006). CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science 314: 294-297.
38. Jin C, Liao X. (1999). Backbone dynamics of a winged helix protein and its DNA complex at different temperatures: changes of internal motions in genesis upon binding to DNA. J Mol Biol 292: 641-651.
39. Kaestner KH, Knochel W, Martinez DE. (2000). Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev 14: 142-146.
40. Kaufmann E, Muller D, Knochel W. (1995). DNA recognition site analysis of Xenopus winged helix proteins. J Mol Biol 248: 239-254.
41. Kobayashi Y, Furukawa-Hibi Y, Chen C, Horio Y, Isobe K, Ikeda K et al. (2005). SIRT1 is critical regulator of FOXO-m ediated transcription in response to oxidative stress. Int J Mol Med 16: 237-243.
42. Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, Burgering BM. (1999). Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398: 630-634.
43. Lai E, Clark KL, Burley SK, Darnell Jr JE. (1993). Hepatocyte nuclear factor 3/fork head or 'winged helix' proteins: a family of transcription factors of diverse biologic function. Proc Natl Acad Sci USA 90: 10421-10423.
44. Lehmann OJ, Sowden JC, Carlsson P, Jordan T, Bhattacharya SS. (2003). Fox's in development and disease. Trends Genet 19: 339-344.
45. Lehtinen MK, Yuan Z, Boag PR, Yang Y, Villen J, Becker EB et al. (2006). A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 125: 987-1001.
46. Lin K, Dorman JB, Rodan A, Kenyon C. (1997). daf-16: an HNF-3/ forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278: 1319-1322.
47. Liu D, Bienkowska J, Petosa C, Collier RJ, Fu H, Liddington R. (1995). Crystal structure of the zeta isoform of the 14-3-3 protein. Nature 376: 191-194.
48. Liu PP, Chen YC, Li C, Hsieh YH, Chen SW, Chen SH et al. (2002). Solution structure of the DNA-binding domain of interleukin enhancer binding factor 1 (FOXK1a). Proteins 49: 543-553.
49. Marsden I, Jin C, Liao X. (1998). Structural changes in the region directly adjacent to the DNA-binding helix highlight a possible mechanism to explain the observed changes in the sequence-specific binding of winged helix proteins. J Mol Biol 278: 293-299.
50. Matsuzaki H, Daitoku H, Hatta M, Aoyama H, Yoshimochi K, Fukamizu A. (2005). Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc Natl Acad Sci USA 102: 11278-11283.
51. Matsuzaki H, Daitoku H, Hatta M, Tanaka K, Fukamizu A. (2003). Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc Natl Acad Sci USA 100: 11285-11290.
52. Mazet F, Yu JK, Liberles DA, Holland LZ, Shimeld SM. (2003). Phylogenetic relationships of the Fox (Forkhead) gene family in the Bilateria. Gene 316: 79-89.
53. Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W et al. (2004). Mammalian SIRT1 represses forkhead transcription factors. Cell 116: 551-563.
54. Muslin AJ, Tanner JW, Allen PM, Shaw AS. (1996). Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84: 889-897.
55. Muslin AJ, Xing H. (2000). 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal 12: 703-709.
56. Nakae J, Park BC, Accili D. (1999). Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. J Biol Chem 274: 15982-15985.
57. O'Brien RM, Granner DK. (1996). Regulation of gene expression by insulin. Physiol Rev 76: 1109-1161.
58. Obsil T, Ghirlando R, Anderson DE, Hickman AB, Dyda F. (2003). Two 14-3-3 binding motifs are required for stable association of Forkhead transcription factor FOXO4 with 14-3-3 proteins and inhibition of DNA binding. Biochemistry 42: 15264-15272.
59. Obsil T, Ghirlando R, Klein DC, Ganguly S, Dyda F. (2001). Crystal structure of the 14-3-3zeta:serotonin N-acetyltransferase complex. a role for scaffolding in enzyme regulation. Cell 105: 257-267.
60. Obsilova V, Vecer J, Herman P, Pabianova A, Sulc M, Teisinger J et al. (2005). 14-3-3 Protein interacts with nuclear localization sequence of forkhead transcription factor FoxO4. Biochemistry 44: 11608-11617.
61. Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA et al. (1997). The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C.elegans. Nature 389: 994-999.
62. Oh SW, Mukhopadhyay A, Svrzikapa N, Jiang F, Davis RJ, Tissenbaum HA. (2005). JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16. Proc Natl Acad Sci USA 102: 4494-4499.
63. Overdier DG, Porcella A, Costa RH. (1994). The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix. Mol Cell Biol 14: 2755-2766.
64. Parry P, Wei Y, Evans G. (1994). Cloning and characterization of the t(X;11) breakpoint from a leukemic cell line identify a new member of the forkhead gene family. Genes Chromosomes Cancer 11: 79-84.
65. Pierrou S, Hellqvist M, Samuelsson L, Enerback S, Carlsson P. (1994). Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending. EMBO J 13: 5002-5012.
66. Plas DR, Thompson CB. (2003). Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J Biol Chem 278: 12361-12366.
67. Rena G, Guo S, Cichy SC, Unterman TG, Cohen P. (1999). Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem 274: 17179-17183.
68. Rena G, Prescott AR, Guo S, Cohen P, Unterman TG. (2001). Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting. Biochem J 354: 605-612.
69. Rena G, Woods YL, Prescott AR, Peggie M, Unterman TG, Williams MR et al. (2002). Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J 21: 2263-2271.
70. Rittinger K, Budman J, Xu J, Volinia S, Cantley LC, Smerdon SJ et al. (1999). Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. Mol Cell 4: 153-166.
71. Seimiya H, Sawada H, Muramatsu Y, Shimizu M, Ohko K, Yamane K et al. (2000). Involvement of 14-3-3 proteins in nuclear localization of telomerase . EMBO J 19: 2652-2661.
72. Sheng W, Rance M, Liao X. (2002). Structure comparison of two conserved HNF-3/fkh proteins HFH-1 and genesis indicates the existence of folding differences in their complexes with a DNA binding sequence. Biochemistry 41: 3286-3293.
73. Shiyanova T, Liao X. (1999). The dissociation rate of a winged helix protein - DNA complex is influenced by non-DNA contact residues. Arch Biochem Biophys 362: 356-362.
74. Streeper RS, Svitek CA, Chapman S, Greenbaum LE, Taub R, O'Brien RM. (1997). A multicomponent insulin response sequence mediates a strong repression of mouse glucose-6-phosphatase gene transcription by insulin. J Biol Chem 272: 11698-11701.
75. Stroud JC, Wu Y, Bates DL, Han A, Nowick K, Paabo S et al. (2006). Structure of the forkhead domain of FOXP2 bound to DNA. Structure 14: 159-166.
76. Sunayama J, Tsuruta F, Masuyama N, Gotoh Y. (2005). JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J Cell Biol 170: 295-304.
77. Sutton J, Costa R, Klug M, Field L, Xu D, Largaespada DA et al. (1996). Genesis, a winged helix transcriptional repressor with expression restricted to embryonic stem cells. J Biol Chem 271: 23126-23133.
78. Takaishi H, Konishi H, Matsuzaki H, Ono Y, Shirai Y, Saito N et al. (1999). Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Proc Natl Acad Sci USA 96: 11836-11841.
79. Tang ED, Nunez G, Barr FG, Guan KL. (1999). Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 274: 16741-16746.
80. Tran H, Brunet A, Griffith EC, Greenberg ME. (2003). The many forks in FOXO's road. Sci STKE 2003: RE5.
81. Tsai KL, Huang CY, Chang CH, Sun YJ, Chuang WJ, Hsiao CD. (2006). Crystal structure of the human FOXK1a - DNA complex and its implications on the diverse binding specificity of winged helix/forkhead proteins. J Biol Chem 281: 17400-17409.
82. Tsai KL, Sun YJ, Huang CY, Yang JY, Hung MC, Hsiao CD. (2007). Crystal structure of the human FOXO3a-DBD/DNA complex suggests the effects of post-translational modification. Nucleic Acids Res 35: 6984-6994.
83. Tsuruta F, Sunayama J, Mori Y, Hattori S, Shimizu S, Tsujimoto Y et al. (2004). JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J 23: 1889-1899.
84. Tzivion G, Luo Z, Avruch J. (1998). A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature 394: 88-92.
85. Tzivion G, Shen YH, Zhu J. (2001). 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 20: 6331-6338.
86. Van Der Heide LP, Hoekman MF, Smidt MP. (2004). The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J 380: 297-309.
87. van der Heide LP, Jacobs FM, Burbach JP, Hoekman MF, Smidt MP. (2005). FoxO6 transcriptional activity is regulated by Thr26 and Ser184, independent of nucleo-cytoplasmic shuttling. Biochem J 391: 623-629.
88. Van Der Hoeven PC, Van Der Wal JC, Ruurs P, Van Dijk MC, Van Blitterswijk J. (2000). 14-3-3 isotypes facilitate coupling of protein kinase C-zeta to Raf-1: negative regulation by 14-3-3 phosphorylation. Biochem J 345(Part 2): 297-306.
89. van der Horst A, Burgering BM. (2007). Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 8: 440-450.
90. van der Horst A, de Vries-Smits AM, Brenkman AB, van Triest MH, van den Broek N, Colland F et al. (2006). FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat Cell Biol 8: 1064-1073.
91. van der Horst A, Tertoolen LG, de Vries-Smits LM, Frye RA, Medema RH, Burgering BM. (2004). FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(-SIRT1). J Biol Chem 279: 28873-28879.
92. van Dongen MJ, Cederberg A, Carlsson P, Enerback S, Wikstrom M. (2000). Solution structure and dynamics of the DNA-binding domain of the adipocyte-transcription factor FREAC-11. J Mol Biol 296: 351-359.
93. Vielhaber E, Eide E, Rivers A, Gao ZH, Virshup DM. (2000). Nuclear entry of the circadian regulator mPER1 is controlled by mammalian casein kinase I epsilon. Mol Cell Biol 20: 4888-4899.
94. Vincenz C, Dixit VM. (1996). 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules. J Biol Chem 271: 20029-20034.
95. Vogt PK, Jiang H, Aoki M. (2005). Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle 4: 908-913.
96. Wang MC, Bohmann D, Jasper H. (2005). JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell 121: 115-125.
97. Wang Y, Oh SW, Deplancke B, Luo J, Walhout AJ, Tissenbaum HA. (2006). C.elegans 14-3-3 proteins regulate life span and interact with SIR-2.1 and DAF-16/FOXO. Mech Ageing Dev 127: 741-747.
98. Weigel D, Jackle H. (1990). The fork head domain - a novel DNA-binding motif of eukaryotic transcription factors. Cell 63: 455-456.
99. Weigel D, Jurgens G, Kuttner F, Seifert E, Jackle H. (1989). The homeotic gene fork head encodes a nuclear-protein and is expressed in the terminal regions of the Drosophila embryo. Cell 57: 645-658.
100. Weigelt J, Climent I, Dahlman-Wright K, Wikstrom M. (2001). Solution structure of the DNA binding domain of the human forkhead transcription factor AFX (FOXO4). Biochemistry 40: 5861-5869.
101. Woods YL, Rena G, Morrice N, Barthel A, Becker W, Guo S et al. (2001). The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. Biochem J 355: 597-607.
102. Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, Stroud JC et al. (2006). FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126: 375-387.
103. Xiao B, Smerdon SJ, Jones DH, Dodson GG, Soneji Y, Aitken A et al. (1995). Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature 376: 188-191.
104. Yaffe MB. (2002). How do 14-3-3 proteins work? Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett 513: 53-57.
105. Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers H et al. (1997). The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91: 961-971.
106. Zhang S, Xing H, Muslin AJ. (1999). Nuclear localization of protein kinase U-alpha is regulated by 14-3-3. J Biol Chem 274: 24865-24872.
107. Zhang X, Gan L, Pan H, Guo S, He X, Olson ST et al. (2002). Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding. J Biol Chem 277: 45276-45284.
108. Zhao X, Gan L, Pan H, Kan D, Majeski M, Adam SA et al. (2004). Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms. Biochem J 378: 839-849.
109. Zhu J, Shibasaki F, Price R, Guillemot JC, Yano T, Dotsch V et al. (1998). Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1. Cell 93: 851-861.